Stock Taper
CNMD
CONMED CORPORATION
NYSE
$49.85
▼ DOWN 0.26% (-0.13)

KEY STATISTICS

Market Cap$1.49 B
52w High$56.64
52w Low$31.44
Dividend Yield1.54%
FrequencyQuarterly
P/E10.96
Volume288.05K
Shares Out.29.95M

COMPANY

LEADERSHIP

Patrick J. Beyer
CHIEF EXECUTIVE
Patrick J. Beyer

COMPENSATION 2026

Salary$891,100
Stock Awards$2,499,971
Incentive Plan Pay$1,129,469
All Other Comp.$614,356
Total$7,634,873

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 23, 1987
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
3,900

PRICE TARGET

Target High$39.00
Target Low$36.00
Target Median$37.50
Target Consensus$37.50

UPCOMING EARNINGS

DateNov 4, 2026
DayWednesday
Rev. Est.$336.25M
NOV
4
WED

SPLIT RECORD

DATETYPERATIO
2001-09-10Forward3:2
1995-12-01Forward3:2
1994-12-28Forward3:2

PRICE

$49.85 ▼ DOWN 0.26% (−$0.13)
OVERLAYS
$49.20$49.50$49.80$50.109:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM49.85

About CONMED Corporation

https://www.conmed.com ↗

CONMED Corporation develops and sells surgical, orthopedic, endoscopic, and cardiac medical devices worldwide, serving healthcare providers with innovative products for minimally invasive procedures, soft tissue repair, and diagnostics.

INDUSTRY

Medical - Devices

A PRODUCT CONMED CORPORATION IS KNOWN FOR

BioBrace® RC Implant Delivery System
BioBrace® RC Implant Delivery System

An arthroscopic delivery system for the BioBrace® implant, designed to simplify and enhance the surgical repair of rotator cuffs. It provides mechanical reinforcement and promotes biological healing to improve patient outcomes.

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
General Surgery$199.73M $215.82M $169.38M $191.17M
Orthopedic Surgery$138.19M $157.38M $147.66M $152.31M

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$193.98M $206.24M $173.06M $175.38M
EMEA$58.68M $74.52M $69.14M $76.15M
Asia Pacific$53.83M $59.1M $41.96M $57.16M
Americas Excluding The United States$31.44M $33.34M $32.9M $34.8M

RATINGS SNAPSHOT

Overall rating: B+

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity3
Return On Assets4
Debt To Equity1
Price To Earnings2
Price To Book4
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Van Taylor
Van Taylor
Purchase
2019-02-15

INSIDER TRADES

OFFICER: EXECUTIVE VICE PRESIDENT & CFO
Gallagher John E
· —
2026-07-15
OFFICER: EXECUTIVE VICE PRESIDENT & CFO
Gallagher John E
Purchase · 35.1K shares
2026-07-15
OFFICER: EXECUTIVE VICE PRESIDENT & CFO
Gallagher John E
Purchase · 30.5K shares
2026-07-15
OFFICER: EXECUTIVE VICE PRESIDENT & CFO
Gallagher John E
Purchase · 26.9K shares
2026-07-15

MOST RECENT ANALYST GRADES

GRADE SUMMARY
NEUTRAL 2
EQUAL WEIGHT 1
UNDERPERFORM 1
HOLD 1
5 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
NEOG$11.55COMPARE
UFPT$295.13COMPARE
NVCR$17.73COMPARE
ESTA$68.64COMPARE
NTLA$12.64COMPARE
AZTA$32.75COMPARE
KMTS$25.30COMPARE
INMD$14.90COMPARE